These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9427169)

  • 1. Fixed drug eruption caused by tosufloxacin tosilate.
    Nishijima S; Nakagawa M
    J Int Med Res; 1997; 25(6):359-63. PubMed ID: 9427169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed drug eruption induced by tosufloxacin tosilate.
    Sangen Y; Kawada A; Asai M; Aragane Y; Yudate T; Tezuka T
    Contact Dermatitis; 2000 May; 42(5):285. PubMed ID: 10789850
    [No Abstract]   [Full Text] [Related]  

  • 3. Tosufloxacin tosilate-induced thrombocytopenic purpura.
    Takahama H; Tazaki H
    J Dermatol; 2007 Jul; 34(7):465-7. PubMed ID: 17584324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced pneumonitis with eosinophilic infiltration due to tosufloxacin tosilate].
    Kimura N; Miyazaki E; Matsuno O; Abe Y; Tsuda T
    Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):618-22. PubMed ID: 9805914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and safety assessment of tosufloxacin tosilate.
    Niki Y
    J Infect Chemother; 2002 Mar; 8(1):1-18. PubMed ID: 11957114
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tosufloxacin tosilate].
    Shimada K
    Jpn J Antibiot; 1990 Apr; 43(4):583-602. PubMed ID: 2199687
    [No Abstract]   [Full Text] [Related]  

  • 7. Fixed drug eruption caused by sulfaguanidine.
    Arias J; Fernández-Rivas M; Martinez M; Senent C
    Dermatology; 1994; 189(2):196-7. PubMed ID: 8075454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tosufloxacin in the treatment of nongonococcal urethritis, including Chlamydia trachomatis.
    Tanaka M; Matsumoto T; Kumazawa J; Nakayama H; Urabe H; Miyazaki Y; Kano M; Nanri K
    Clin Ther; 1994; 16(5):819-23. PubMed ID: 7859241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone-induced generalized fixed drug eruption.
    Hager JL; Mir MR; Hsu S
    Dermatol Online J; 2009 Dec; 15(12):8. PubMed ID: 20040258
    [No Abstract]   [Full Text] [Related]  

  • 10. Fixed-drug eruption due to metronidazole with positive topical provocation.
    Gastaminza G; Anda M; Audicana MT; Fernandez E; Muñoz D
    Contact Dermatitis; 2001 Jan; 44(1):36. PubMed ID: 11156011
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary infiltration with eosinophilia (PIE) syndrome induced by antibiotics, PIPC and TFLX during cancer treatment.
    Yamamoto T; Tanida T; Ueta E; Kimura T; Doi S; Osaki T
    Oral Oncol; 2001 Jul; 37(5):471-5. PubMed ID: 11377237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sparfloxacin-induced nail pigmentation: A case of fixed drug eruption?
    Yahya H
    Ann Afr Med; 2018; 17(1):40-42. PubMed ID: 29363635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-pigmenting fixed drug eruption due to fluoroquinolones.
    Gupta LK; Beniwal R; Khare AK; Mittal A; Mehta S; Balai M
    Indian J Dermatol Venereol Leprol; 2017; 83(1):108-112. PubMed ID: 27647361
    [No Abstract]   [Full Text] [Related]  

  • 14. Nonpigmenting solitary fixed drug eruption caused by a Chinese traditional herbal medicine, ma huang (Ephedra Hebra), mainly containing pseudoephedrine and ephedrine.
    Matsumoto K; Mikoshiba H; Saida T
    J Am Acad Dermatol; 2003 Apr; 48(4):628-30. PubMed ID: 12664035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of fixed drug eruption due to ephedrine hydrochloride].
    Tanimoto K; Shimakage T; Ayabe Y; Yamakawa T; Kumekawa M; Moriyama S
    Masui; 2000 Dec; 49(12):1374-6. PubMed ID: 11193515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unusual form of crystal-forming chronic interstitial nephritis following long-term exposure to tosufloxacin tosilate.
    Okada H; Watanabe Y; Kotaki S; Ikeda N; Takane H; Kanno Y; Sugahara S; Ban S; Nagata M; Suzuki H
    Am J Kidney Dis; 2004 Nov; 44(5):902-7. PubMed ID: 15492957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fixed drug eruption in Bangladeshi population: confirmed by provocative test.
    Rahman MH
    Int J Dermatol; 2014 Feb; 53(2):255-8. PubMed ID: 23968227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case no. 6. Bullous dermatosis].
    Ortonne N
    Ann Pathol; 2013 Jun; 33(3):202-6. PubMed ID: 23790662
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous reaction to naproxen.
    Gonzalo Garijo MA; Bobadilla González P
    Allergol Immunopathol (Madr); 1996; 24(2):89-92. PubMed ID: 8933896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biliary excretion and clinical efficacy of T-3262 (tosufloxacin tosilate) administered in the treatment of cholecystitis].
    Sugata F; Ohguri S; Takamura Y; Tominaga S; Iwamura K; Yamada T; Shibata H; Yamada N; Okabe K; Kato Y
    Jpn J Antibiot; 1989 Sep; 42(9):1873-81. PubMed ID: 2810750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.